Transcranial Photobiomodulation for Anxiety Symptoms

Transcranial Photobiomodulation in Anxiety Disorders

Recruiting N/A Interventional Study
Symptoms of Anxiety
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
280 (estimated)
Sponsor
Francisco Gonzalez-Lima, PhD · Other
Who this trial is looking for

This trial is looking for adults with moderate sub-clinical anxiety. Participants will receive a light treatment aimed at reducing their anxiety symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years of age or older
  • I have a State-Trait Anxiety Index score between 40-59
  • I have a Patient Health Questionnaire score between 1-9

You may not be able to join if

  • I have a State-Trait Anxiety Index score less than 40 or greater than 59
  • I have a Patient Health Questionnaire score greater than 9
  • I have had a change in my medications in the last 6 weeks
  • I have indicated suicidal thoughts
  • I am currently receiving transcranial photobiomodulation treatment
  • I am currently pregnant

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety) * Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression) Exclusion Criteria: * STAI sc…
Contacts

Francisco Gonzalez-Lima, Ph.D.

512-537-5257

utanxietystudy1@gmail.com

CONTACT